MET
Aliases: Methylethyltryptamine
Summary
N-Ethyl-N-methyltryptamine (also known as Methylethyltryptamine, and MET) is a lesser-known novel psychedelic substance of the tryptamine class that produces powerful and short-lived psychedelic effects when administered. It is structurally related to DMT and is similarly unique among psychedelics due to its short-lived effects, rapid onset and progressive stages.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Smoked/Vaporized | 20-40mg | 40-60mg | 60-90mg | 90mg+ |
| Oral | 60-120mg | 120-150mg | 150-200mg | 200mg+ |
| Insufflated | 10-20mg | 20-25mg | 25-35mg | 35mg+ |
| Smoked | 20-40mg | 40-60mg | 60-90mg | 90mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Smoked/Vaporized | 0-1 min | 1-4 min | 10-19 min | 19-40 min |
| Oral | 19-45 min | 30-60 min | 1-2 hrs | 1-2 hrs |
| Insufflated | 4-15 min | 10-19 min | 30-90 min | 45-90 min |
Effect Profile
14 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Psychedelic
6.0
Strong
6/10
Strong visuals with mild headspace and body load
Visual Intensity
×3
10
visual geometry
internal hallucinations
color enhancement
drifting
tracers
brightened colour
Headspace Depth
×3
4
thought connectivity
time distortion
confusion
Auditory Effects
×1
0
Body Load / Somatic Effects
×1
4
nausea
muscle tension
Based on reports from:
Tolerance
Build-up
develops rapidly after a single use
Reset
7โ14 days for baseline
Tolerance Decay
Full tolerance
1h
Half tolerance
10d
Baseline
~14d
Effects
Aggregated from 14 Erowid experience reports
Positive Effects 7
Music Enhancement
57.1%
70%
Stimulation
57.1%
70%
Euphoria
50.0%
70%
Empathy
50.0%
70%
Color Enhancement
35.7%
70%
Focus Enhancement
28.6%
70%
Body High
21.4%
70%
Adverse Effects 1
Confusion
21.4%
70%
Combinations
MET's nerd page
Pharmacology, chemical data, effect profiles, and more
→